Overexpression of the Wilms' tumor gene W T1 in primary astrocytic tumors

Cancer Sci. 2004 Oct;95(10):822-7. doi: 10.1111/j.1349-7006.2004.tb02188.x.

Abstract

Expression of the Wilms' tumor gene W T1 in primary astrocytic tumors was examined using a quantitative real-time reverse transcriptase-polymerase chain reaction (RT-PCR) or immunohistochemistry. Real-time RT-PCR showed that W T1 mRNA was expressed at various levels in all of the 25 astrocytic tumors examined. Immunohistochemical analysis showed that W T1 protein was expressed in 5 of 6 low-grade astrocytic tumors (grade I-II) and all of 18 high-grade ones (grade III-IV), and that expression levels of W T1 protein in high-grade tumors were significantly higher than those in low-grade ones. W T1 protein was not detected in the normal glial cells contained in the tumor specimens. Furthermore, treatment with W T1 antisense oligomers specifically inhibited growth of glioblastoma cell lines, U87-MG, A172, and T-98G. These results may indicate that the W T1 gene plays an important role in tumorigenesis of primary astrocytic tumors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Aged
  • Astrocytoma / genetics*
  • Brain Neoplasms / genetics*
  • Brain Neoplasms / metabolism
  • Cell Line, Tumor
  • Cytoplasm / metabolism
  • Female
  • Gene Expression
  • Genes, Wilms Tumor
  • Glioblastoma / genetics
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Neuroglia / metabolism
  • RNA, Messenger / analysis
  • Reverse Transcriptase Polymerase Chain Reaction
  • Tumor Cells, Cultured
  • WT1 Proteins / metabolism*

Substances

  • RNA, Messenger
  • WT1 Proteins